These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 5899158)
1. [Tuberculosis problems as seen from the viewpoint of chemotherapy]. Ebina T; Kanno I; Kayaba K; Saito T; Kudo S; Tanno S; Ito K Z Tuberk Erkr Thoraxorg; 1965; 124(5):257-74. PubMed ID: 5899158 [No Abstract] [Full Text] [Related]
2. [Molecular medicine and treatment of tuberculosis]. Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966 [No Abstract] [Full Text] [Related]
3. [Effect of a complex preparation of isoniazide on mononuclear cells in tuberculous granuloma]. ShkurupiÄ VA; Chernova TG; Kurunov IuN Biull Eksp Biol Med; 1996 May; 121(5):559-61. PubMed ID: 8744138 [No Abstract] [Full Text] [Related]
4. Latent tuberculosis: models, mechanisms, and novel prospects for eradication. Riska PF; Carleton S Semin Pediatr Infect Dis; 2002 Oct; 13(4):263-72. PubMed ID: 12491232 [TBL] [Abstract][Full Text] [Related]
6. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis. Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701 [TBL] [Abstract][Full Text] [Related]
7. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid]. Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123 [TBL] [Abstract][Full Text] [Related]
11. [Commemorative lecture of receiving Imamura Memorial Prize. Studies on prevention and treatment of childhood tuberculosis]. Takamatsu I Kekkaku; 1999 Nov; 74(11):809-15. PubMed ID: 10599214 [TBL] [Abstract][Full Text] [Related]
12. [Immunotropic activity of antimicrobial agents used in tuberculosis]. Aleksandrova AE; Vinogradova TI Probl Tuberk; 1996; (2):43-5. PubMed ID: 8657696 [TBL] [Abstract][Full Text] [Related]
14. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis. Ahmad Z; Sharma S; Khuller GK FEMS Microbiol Lett; 2006 Aug; 261(2):181-6. PubMed ID: 16907718 [TBL] [Abstract][Full Text] [Related]
15. [Resistance to antitubercular drugs in Chile]. Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808 [No Abstract] [Full Text] [Related]
16. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis. Hearn MJ; Cynamon MH Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921 [TBL] [Abstract][Full Text] [Related]
17. [Antitubercular activity of prothionamide-isoiazid combination. Experimental study]. Arzu G; De Santis G; Ginesu F G Ital Chemioter; 1967; 14(1):58-64. PubMed ID: 5622726 [No Abstract] [Full Text] [Related]
18. Question from the clinician: tuberculosis prophylaxis. Wald E Pediatr Rev; 2003 Oct; 24(10):355. PubMed ID: 14523162 [No Abstract] [Full Text] [Related]
19. Role of individual drugs in the chemotherapy of tuberculosis. Mitchison DA Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648 [TBL] [Abstract][Full Text] [Related]
20. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain. Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]